Crusted Scabies in a Patient being Treated with Spesolimab for Generalized Pustular Psoriasis

Crusted Scabies in a Patient being Treated with Spesolimab for Generalized Pustular Psoriasis

Saved in:

Bibliographic Details
Main Authors:	Hanna Schratter, Thomas Graier, Franz Legat, Rainer Hofmann-Wellenhof, Peter Wolf
Format:	Article
Language:	English
Published:	Medical Journals Sweden 2025-02-01
Series:	Acta Dermato-Venereologica
Subjects:	crusted scabies Generalized pustular psoriasis (GPP) spesolimab
Online Access:	https://medicaljournalssweden.se/actadv/article/view/42177
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effectiveness and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Single-centre Retrospective Study
by: Yoshiki Okada, et al.
Published: (2025-02-01)

Generalized pustular psoriasis: a multicentric study on patient characteristics and clinical burden
by: Cristina Bulai Livideanu, et al.
Published: (2025-02-01)

Post-COVID-19 resurgence of scabies’ cases in the Lazio Region, Italy: a new emerging public health threat?
by: Martina Spaziante, et al.
Published: (2025-02-01)

Beyond the dichotomy: understanding the overlap between atopic dermatitis and psoriasis
by: Mengmeng Li, et al.
Published: (2025-02-01)

Efficacy and safety of ustekinumab in the treatment of moderate to severe plaque psoriasis in Singapore
by: Wai Sze Agnes Chan, et al.
Published: (2023-07-01)

Managing pediatric psoriasis: update on treatments and challenges—a review
by: A. A. Hebert, et al.
Published: (2022-07-01)

Biological therapy in the reduction of cardiovascular risk in patients with psoriasis
by: Andrés Tirado-Sánchez
Published: (2025-01-01)

Dermatological Disorders Associated with Pregnancy
by: Grzegorz Szcześniak, et al.
Published: (2025-02-01)

A New Diagnosing Method for Psoriasis From Exhaled Breath
by: Bilge Han Tozlu, et al.
Published: (2025-01-01)

Reactivation of latent hepatitis B infection during immunosuppressive therapy with guselkumab for plaque psoriasis: a case report
by: Elena Franchi, et al.
Published: (2023-12-01)

Treatment goals and preferences of pediatric psoriasis patients, young adults, and parents
by: Mirjam J. Schaap, et al.
Published: (2022-07-01)

Association between the exposure to brominated flame retardants and psoriasis risk among U.S. adults: A population-based study
by: Jingbo Zhang, et al.
Published: (2025-02-01)

Psoriasis: Unraveling Disease Mechanisms and Advancing Pharmacological and Nanotechnological Treatments
by: Miao M, et al.
Published: (2025-02-01)

PEPITEM, its tripeptide pharmacophores and their peptidomimetic analogues regulate the inflammatory response through parenteral and topical dosing in models of peritonitis and psoriasis
by: Anella Saviano, et al.
Published: (2025-03-01)

Lack of reactivation of tuberculosis in patients with psoriasis treated with secukinumab in a real-world setting of latent tuberculosis infection
by: Matteo Megna, et al.
Published: (2022-07-01)

Hyperglycemia Is a Potential Prognostic Factor for Exacerbation in Severe Psoriasis with Diabetes or Prediabetes
by: Yongpisarn T, et al.
Published: (2025-02-01)

The influence of uterine leiomyomatosis on the onset of psoriasis: a nationwide population-based study of 2.5 million Korean females
by: Yeong Ho Kim, et al.
Published: (2025-02-01)

Long-term maintenance treatment of psoriasis: the role of calcipotriol/betamethasone dipropionate aerosol foam in clinical practice
by: Gabriella Fabbrocini, et al.
Published: (2022-07-01)

Obesity mediates the association between psoriasis and diabetes incidence: a population-based study
by: Zuojiao Xu, et al.
Published: (2025-02-01)

Sex Disparities of Health-related Quality of Life in Moderate to Severe Psoriasis: A Real-world Analysis from the Swiss Psoriasis Registry (SDNTT)
by: Ramtin Lichtenberger, et al.
Published: (2025-02-01)

Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial
by: Selma Atalay, et al.
Published: (2022-07-01)

Pruritic Maculopapular Eruption of a 4-month-old Baby: A Quiz
by: Gustavo Almeida-Silva, et al.
Published: (2025-02-01)

Neuroimmunology of psoriasis: Possible roles for calcitonin gene-related peptide in its pathogenesis
by: Joshua Kotlyar, et al.
Published: (2025-03-01)

Inorganic polyphosphate and the stringent response coordinately control cell division and cell morphology in Escherichia coli
by: Christopher W. Hamm, et al.
Published: (2025-02-01)

Biological Soil Crusts in Agroecosystems
by: Kira Sorochkina, et al.
Published: (2023-10-01)

Efficacy and safety of Janus kinase inhibitors in the treatment of psoriasis and psoriatic arthritis: An analysis of evidence from 2014 to 2022
by: Jiao Wang, et al.
Published: (2025-02-01)

Variations in the physicochemical properties of soil, enzyme activities, and the characteristics of bacterial communities within algal biocrusts and subsoils across different plant communities
by: Haonian Li, et al.
Published: (2025-04-01)

Fluids, faulting and earthquakes in the brittle crust: recent advances and new challenges
by: Fabbri, Olivier, et al.
Published: (2024-05-01)

Missed, but Momentous: A Comprehensive Review of Neglected Tropical Skin Diseases in Southern India and their Global Impact
by: Ramesha M Bhat, et al.
Published: (2025-01-01)

Microneedle-Based Approaches for Skin Disease Treatment
by: Yanhua Han, et al.
Published: (2025-02-01)

Single-cell RNA sequencing of circulating immune cells supports inhibition of TNFAIP3 and NFKBIA translation as psoriatic arthritis biomarkers
by: Ameth N. Garrido, et al.
Published: (2025-02-01)

Psoriasis : diagnostisches und therapeutisches Management /

Psoriasis : diagnostisches und therapeutisches Management /
Published: (2009)

Psoriasis : diagnostisches und therapeutisches Management /
Published: (2009)

Effectiveness, speed of action and safety of brodalumab in elderly psoriasis patients: a multicenter real-world study – IL PSO (Italian Landscape Psoriasis)
by: D. Orsini, et al.
Published: (2025-12-01)

Drug Insurance and Psoriasis Severity: A Retrospective Cohort Study
by: Laurence Mainville, et al.
Published: (2025-02-01)

Editorial: Impact of the innate and adaptive immune system in driving type 1 inflammatory skin disease
by: Mark Mellett, et al.
Published: (2025-02-01)

Pregnancy outcomes in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis receiving ixekizumab
by: A. Egeberg, et al.
Published: (2022-07-01)

Relative Importance of Mode of Administration in Treatment Preferences among Plaque Psoriasis Patients in the United States
by: Steven R. Feldman, et al.
Published: (2016-08-01)

Efficacy and safety of various drug combinations in treating plaque Psoriasis: A meta-analysis [version 2; peer review: 2 approved]
by: Nayak Snehasis, et al.
Published: (2025-01-01)